A role for pharmacotherapy in the treatment of "internet addiction"

Clinical Neuropharmacology

Volumn 35, Issue 6, 2012, Pages 283-289

  Camardese, Giovanni ^a   De Risio, Luisa ^a   Di Nicola, Marco ^a   Pizi, Giusy ^a   Janiri, Luigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

comorbidity; Internet addiction; pharmacological treatment

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; ESCITALOPRAM; GUANFACINE; LITHIUM; MEMANTINE; METHYLPHENIDATE; NALTREXONE; OLANZAPINE; QUETIAPINE; RILUZOLE; RISPERIDONE; SERTRALINE; VALPROIC ACID;

BEHAVIOR DISORDER; CAVERNOSOGRAPHY; COMORBIDITY; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG EFFICACY; DRUG INDICATION; DSM-IV-TR; HUMAN; INTERNET ADDICTION; KLEPTOMANIA; MAJOR DEPRESSION; OBSESSIVE COMPULSIVE DISORDER; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; HUMANS; INTERNET; MAGNETIC RESONANCE IMAGING; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 84870047272     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31827172e5     Document Type: Review

References (69)

1. Tao R, Huang X, Wang J, et al. Proposed diagnostic criteria for Internet addiction. Addiction 2010;105(3):556-564.
2. Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol 2008;59:29-53.
3. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997;278(5335):52-58. (Pubitemid 27446270)
4. Goodman A. Addiction: definition and implications. Br J Addict 1990;85(11):1403-1408. (Pubitemid 20377626)
5. Grant JE, Potenza MN, Weinstein A, et al. Introduction to behavioral addictions. Am J Drug Alcohol Abuse 2010;36(5):233-241.
6. Griffiths M. Does Internet and computer "addiction" exist? Some case study evidence. CyberPsychol Behav 2000;3(2):211-218. (Pubitemid 30225259)
7. American Psychiatric Association. Diagnostic Criteria From DSM-IVTR. Washington, DC: American Psychiatric Association; 2000.
8. Holden C. Psychiatry. Behavioral addictions debut in proposed DSM-V. Science 2010;327(5968):935.
9. World Health Organization. International Classification of Mental and Behavioral Disorders (10th Edition, ICD-10). Geneva, Switzerland: World Health Organization ed; 2010.
10. Goldberg I. Criteria for Internet addiction disorder. Published in http://www.aspen.uml.edu; 1995. Available at: http://www.psycom.net/iadcriteria. html. Accessed April 30, 2012.
11. Davis RA. A cognitive-behavioral model of pathological internet use (PIU). Comput Hum Behav 2001;17(2):187-195. (Pubitemid 32874378)
12. Young KS. Caught in the Net: How to Recognize the Signs of Internet Addiction and a Winning Strategy for Recovery. New York: John Wiley; 1998.
13. Young KS. Internet addiction: the emergence of a new clinical disorder. CyberPsychol Behav 1998;1(3):237-244. (Pubitemid 128540410)
14. Shapira NA, Lessig MC, Goldsmith TD, et al. Problematic Internet use: proposed classification and diagnostic criteria. Depress Anxiety 2003;17(4):207-216. (Pubitemid 36828746)
15. Griffiths M. Nicotine, tobacco and addiction. Nature 1996;384(6604):18.
16. Ko CH, Yen JY, Chen CC, et al. Proposed diagnostic criteria of Internet addiction for adolescents. J Nerv Ment Dis 2005;193(11):728-733.
17. Shapira NA, Goldsmith TD, Keck PE Jr, et al. Psychiatric features of individuals with problematic Internet use. J Affect Disord 2000;57(1-3):267-272. (Pubitemid 30119983)
18. Block JJ. Issues for DSM-V: Internet addiction. Am J Psychiatry 2008;165(3):306-307. (Pubitemid 351704482)
19. Blum K, Chen AL, Chen TJ, et al. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model 2008;5:24.
20. King DL, Delfabbro PH, Griffiths MD, et al. Assessing clinical trials of Internet addiction treatment: a systematic review and CONSORT evaluation. Clin Psychol Rev 2011;31(7):1110-1116.
21. Liu J, Gao XP, Osunde I, et al. Increased regional homogeneity in Internet addiction disorder: a resting state functional magnetic resonance imaging study. Chin Med J (Engl) 2010;123(14):1904-1908.
22. Ko CH, Liu GC, Hsiao S, et al. Brain activities associated with gaming urge of online gaming addiction. J Psychiatr Res 2009;43(7):739-747.
23. Dowling NA, Brown M. Commonalities in the psychological factors associated with problem gambling and Internet dependence. Cyberpsychol Behav Soc Netw 2010;13(4):437-441.
24. Yen JY, Ko CH, Yen CF, et al. The comorbid psychiatric symptoms of Internet addiction: attention deficit and hyperactivity disorder (ADHD), depression, social phobia, and hostility. J Adolesc Health 2007;41(1):93-98.
25. Goddard AW, Shekhar A, Whiteman AF, et al. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today 2008;13(7-8):325-332.
26. Grant JE, Kim SW, Odlaug BL. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry 2009;65(7):600-606.
27. Kim SW, Grant JE, Grosz RL. Pathological gambling. Current status and new treatments. Minn Med 2002;85(7):48-50, 52.
28. Koran LM, Aboujaoude EN, Gamel NN. Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. J Clin Psychiatry 2007;68(3):422-427. (Pubitemid 46506808)
29. Koran LM, Bullock KD, Hartston HJ, et al. Citalopram treatment of compulsive shopping: an open-label study. J Clin Psychiatry 2002;63(8):704-708.
30. Sattar P, Ramaswamy S. Internet gaming addiction. Can J Psychiatry 2004;49(12):869-870.
31. Dell'Osso B, Hadley S, Allen A, et al. Escitalopram in the treatment of impulsive-compulsive Internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. J Clin Psychiatry 2008;69(3):452-456. (Pubitemid 351549399)
32. Han DH, Lee YS, Na C, et al. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder. Compr Psychiatry 2009;50(3):251-256.
33. Han DH, Renshaw PF. Bupropion in the treatment of problematic online game play in patients with major depressive disorder. J Psychopharmacol 2012;26(5):689-696.
34. Goldberg JF, Whiteside JE. The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry 2002;63(9):791-795.
35. Bernardi S, Pallanti S. Internet addiction: a descriptive clinical study focusing on comorbidities and dissociative symptoms. Compr Psychiatry 2009;50(6):510-516.
36. Di Chiara G, Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 2007;7(1):69-76. (Pubitemid 46238042)
37. Bostwick JM, Bucci JA. Internet sex addiction treated with naltrexone. Mayo Clin Proc 2008;83(2):226-230. (Pubitemid 351303110)
38. Grant JE, Kim SW, Hollander E, et al. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl) 2008;200(4):521-527.
39. Di Nicola M, Martinotti G, Mazza M, et al. Quetiapine as add-on treatment for bipolar I disorder with comorbid compulsive buying and physical exercise addiction. Prog Neuropsychopharmacol Biol Psychiatry 2010;34(4):713-714.
40. Roncero C, Rodriguez-Urrutia A, Grau-Lopez L, et al. Antiepileptic drugs in the control of the impulses disorders [in Spanish]. Actas Esp Psiquiatr 2009;37(4):205-212.
41. Maremmani I, Pacini M, Lamanna F, et al. Mood stabilizers in the treatment of substance use disorders. CNS Spectr 2010;15(2):95-109.
42. Pallanti S, Quercioli L, Sood E, et al. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry 2002;63(7):559-564. (Pubitemid 34787319)
43. Choi YJ. Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review. J Am Acad Nurse Pract 2009;21(4):207-213.
44. Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006;11(7):622-632. (Pubitemid 43989810)
45. Bystritsky A, Ackerman DL, Rosen RM, et al. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial. J Clin Psychiatry 2004;65(4):565-568.
46. Hollander E, Baldini Rossi N, Sood E, et al. Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. Int J Neuropsychopharmacol 2003;6(4):397-401. (Pubitemid 38146258)
47. Denys D, de Geus F, van Megen HJ, et al. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry 2004;65(8):1040-1048.
48. Maina G, Pessina E, Albert U, et al. 8-Week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. Eur Neuropsychopharmacol 2008;18(5):364-372.
49. Connor KM, Payne VM, Gadde KM, et al. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry 2005;66(1):49-51.
50. Martinotti G, Di Nicola M, Janiri L. Efficacy and safety of aripiprazole in alcohol dependence. Am J Drug Alcohol Abuse 2007;33(3):393-401. (Pubitemid 47037170)
51. Martinotti G, Di Nicola M, Di Giannantonio M, et al. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone. J Psychopharmacol 2009;23(2):123-129.
52. Garnis-Jones S, Collins S, Rosenthal D. Treatment of self-mutilation with olanzapine. J Cutan Med Surg 2000;4(3):161-163.
53. Stewart RS, Nejtek VA. An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. J Clin Psychiatry 2003;64(1):49-52. (Pubitemid 36182229)
54. Christensen RC. Olanzapine augmentation of fluoxetine in the treatment of pathological skin picking. Can J Psychiatry 2004;49(11):788-789. (Pubitemid 40094959)
55. Shoja-Shafti S. Treatment of borderline personality disorder with olanzapine. Arch Iran Med 2006;9(4):403-405. (Pubitemid 44803585)
56. McElroy SL, Nelson EB, Welge JA, et al. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry 2008;69(3):433-440. (Pubitemid 351549397)
57. Di Nicola M, Tedeschi D, Mazza M, et al. Behavioural addictions in bipolar disorder patients: role of impulsivity and personality dimensions. J Affect Disord 2010;125(1-3):82-88.
58. Atmaca M. A case of problematic Internet use successfully treated with an SSRI-antipsychotic combination. Prog Neuropsychopharmacol Biol Psychiatry 2007;31(4):961-962. (Pubitemid 46660287)
59. Han DH, Hwang JW, Renshaw PF. Bupropion sustained release treatment decreases craving for video games and cue-induced brain activity in patients with Internet video game addiction. Exp Clin Psychopharmacol 2010;18(4):297-304.
60. Yoo HJ, Cho SC, Ha J, et al. Attention deficit hyperactivity symptoms and Internet addiction. Psychiatry Clin Neurosci 2004;58(5):487-494. (Pubitemid 39468791)
61. Muir VJ, Perry CM. Guanfacine extended-release: in attention deficit hyperactivity disorder. Drugs 2010;70(13):1693-1702.
62. Kollins SH, Jain R, Brams M, et al. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics 2011;127(6):e1406-e1413.
63. Krystal JH, Petrakis IL, Krupitsky E, et al. NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann N Y Acad Sci 2003;1003:176-184. (Pubitemid 38083055)
64. Grant JE, Chamberlain SR, Odlaug BL, et al. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl) 2010;212(4):603-612.
65. Evans SM, Levin FR, Brooks DJ, et al. A pilot double-blind treatment trial of memantine for alcohol dependence. Alcohol Clin Exp Res 2007;31(5):775-782. (Pubitemid 46587657)
66. Grant P, Song JY, Swedo SE. Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2010;20(4):309-315.
67. Pittenger C, Krystal JH, Coric V. Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder. J Clin Psychiatry 2005;66(11):1492-1493. (Pubitemid 41779556)
68. Sasso DA, Kalanithi PS, Trueblood KV, et al. Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors. J Clin Psychopharmacol 2006;26(6):685-687. (Pubitemid 44772760)
69. Coric V, Kelmendi B, Pittenger C, et al. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania. J Clin Psychiatry 2007;68(1):170-171. (Pubitemid 46220144)